Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/23/2025

Managing Failure to Thrive After Myocardial Infarction in Subacute Rehabilitation

Core Medical Optimization

  • The European Society of Cardiology recommends enrolling patients immediately in a structured cardiac rehabilitation program with aggressive optimization of guideline-directed medical therapy to reduce mortality and improve functional recovery in post-MI patients with poor outcomes 1, 2
  • The European Society of Cardiology suggests that ACE inhibitors (or ARBs if intolerant) must be initiated or uptitrated, particularly critical in patients with heart failure, LVEF <40%, diabetes, or anterior infarction 1, 2
  • The American College of Cardiology recommends that beta-blockers are mandatory in all patients with heart failure or LVEF <40% unless contraindicated, and should be continued indefinitely 1, 2, 3, 4
  • The European Society of Cardiology recommends high-intensity statin therapy (atorvastatin 40-80 mg or rosuvastatin 20-40 mg) to be started immediately with target LDL-C <1.8 mmol/L (70 mg/dL) 1, 2
  • The European Society of Cardiology suggests that dual antiplatelet therapy with aspirin 75-100 mg plus ticagrelor or prasugrel (or clopidogrel if unavailable) should be used for 12 months 1, 2
  • The European Society of Cardiology recommends mineralocorticoid receptor antagonists in patients with EF <40% and heart failure or diabetes who are already on ACE inhibitor and beta-blocker, provided creatinine ≤2.5 mg/dL (men) or ≤2.0 mg/dL (women) and potassium ≤5.0 mEq/L 1, 2, 3

Cardiac Rehabilitation: The Critical Intervention

  • The European Society of Cardiology recommends participation in a formal cardiac rehabilitation program, which is a Class I recommendation and directly addresses failure to thrive through multiple mechanisms 1, 2, 5
  • Cardiac rehabilitation reduces recurrent hospitalizations and healthcare expenditure while prolonging life 5
  • Cardiac rehabilitation improves medication adherence through repeated education and monitoring, and provides supervised exercise that increases functional capacity, with each single-stage increase in physical work capacity reducing all-cause mortality by 8-14% 6
  • Cardiac rehabilitation addresses psychological factors including depression and anxiety that commonly develop post-MI 6, 7, 8
  • The European Society of Cardiology suggests that cardiac rehabilitation should be done 3-5 times per week for meaningful functional improvement, and long-term reinforced programs (extending beyond standard 6-12 weeks) reduce cardiovascular mortality by 33%, non-fatal MI by 36%, and stroke by 32% 5, 6

Addressing Specific Failure to Thrive Components

  • The European Society of Cardiology recommends a Mediterranean-type diet low in saturated fat, high in polyunsaturated fat, and rich in fruits and vegetables to reduce recurrence rates 6
  • The European Society of Cardiology suggests that fish oil n-3 polyunsaturated fatty acids (1 g daily) reduces all-cause mortality and sudden death, and fatty fish should be eaten at least twice weekly 6
  • The American College of Cardiology recommends screening for depression systematically during hospitalization and monthly for the first year, and treating with combined cognitive-behavioral therapy plus selective serotonin reuptake inhibitors when depression is identified 7
  • The European Society of Cardiology recommends providing repeated counseling with nicotine replacement, varenicline, or bupropion for smoking cessation, and nurse-directed protocols are effective 1, 2, 6, 8

Assessment of Cardiac Function

  • The European Society of Cardiology recommends routine echocardiography to assess LV and RV function, detect mechanical complications, and exclude LV thrombus 1, 2
  • The American College of Cardiology suggests that patients with EF 31-40% or lower require Holter monitoring for possible ICD consideration 7

Monitoring and Follow-Up

  • The American College of Cardiology recommends an early follow-up visit (within 2-4 weeks) to assess symptoms, medication tolerance, and titration needs, and to review medication list and uptitrate ACE inhibitors, beta-blockers, and statins toward target doses 7
  • The American College of Cardiology suggests assessing functional class and exercise tolerance, and screening for depression, anxiety, and sleep disorders 7

REFERENCES